The long-term retention of zonisamide in a large cohort of people with epilepsy at a tertiary referral centre

Epilepsy Research

Volumn 96, Issue 1-2, 2011, Pages 39-44

  Catarino, Claudia B ^a,b   Bartolini, Emanuele ^a,c   Bell, Gail S ^a,b   Yuen, Alan W C ^a,b   Duncan, John S ^a,b   Sander, Josemir W ^a,b,d  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b EPILEPSY SOCIETY   (United Kingdom)

^c UNIVERSITY OF PISA   (Italy)

^d STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

Adverse effects; Antiepileptic drugs; Efficacy; Epilepsy; Retention; Zonisamide

Indexed keywords

ANTICONVULSIVE AGENT; ZONISAMIDE;

ADOLESCENT; ADULT; AGED; AGGRESSIVENESS; AGITATION; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CONTROL; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FATIGUE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GENERALIZED EPILEPSY; GRAND MAL SEIZURE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD DISORDER; NEPHROLITHIASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRURITUS; PSYCHOSIS; SEIZURE; SIDE EFFECT; SOMNOLENCE; TERTIARY HEALTH CARE; TREATMENT DURATION; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; COHORT STUDIES; EPILEPSY; FEMALE; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052845510     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.04.012     Document Type: Article

References (29)

1. Alapati A., Hall-Bell C., Faught E.R. Safety and efficacy of zonisamide adjunctive therapy for refractory complex partial seizures: an open label study. Epilepsia 2000, 41(Suppl. 7):225.
2. Baulac M. Introduction to zonisamide. Epilepsy Res. 2006, 68(Suppl. 2):S3-S9.
3. Biton V. Zonisamide: newer antiepileptic agent with multiple mechanisms of action. Expert Rev. Neurother. 2004, 4:935-943.
4. Brodie M.J., Duncan R., Vespignani H., Solyom A., Bitenskyy V., Lucas C. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. Epilepsia 2005, 1:31-41.
5. Chung S., Wang N., Hank N. Comparative retention rates and longterm tolerability of new antiepileptic drugs. Seizure 2007, 16:296-304.
6. Cox D. Regression models and life tables. J. R. Stat. Soc. 1972, 34:187-220.
7. Depondt C., Yuen A.W., Bell G.S., Mitchell T., Koepp M.J., Duncan J.S., Sander J.W. The long term retention of levetiracetam in a large cohort of patients with epilepsy. J. Neurol. Neurosurg. Psychiatry 2006, 77:101-103.
8. Faught E., Ayala R., Montouris G.G., Leppik I.E. Zonisamide 922 Trial Group. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001, 10:1774-1779.
9. French J.A., Ruelle A.D. Zonisamide reduces seizure frequency over time in long-term continuation studies. Epilepsia 2002, 43:241.
10. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958, 53:457-481.
11. Leppik I.E. Practical prescribing and long-term efficacy and safety of zonisamide. Epilepsy Res. 2006, 68S:S17-S24.
12. Leppik I.E., Willmore L.J., Homan R.W., Fromm G., Oommen K.J., Penry J.K., Sackellares J.C., Smith D.B., Lesser R.P., Wallace J.D., et al. Efficacy and safety of zonisamide: results of a multicenter study. Epilepsy Res. 1993, 14:165-173.
13. Lhatoo S.D., Wong I.C.K., Polizzi G., Sander J.W. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy. Epilepsia 2000, 41:1592-1596.
14. Ohtahara S. Zonisamide in the management of epilepsy-Japanese experience. Epilepsy Res. 2006, 68(Suppl. 2):25-33.
15. Sackellares J.C., Ramsay R.E., Wilder B.J., Browne T.R., Shellenberger M.K. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures. Epilepsia 2004, 6:610-617.
16. Schmidt D., Jacob R., Loiseau P., Deisenhammer E., Klinger D., Despland A., Egli M., Bauer G., Stenzel E., Blankenhorn V. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res. 1993, 1:67-73.
17. Schulze-Bonhage A. Zonisamide in the treatment of epilepsy. Expert Opin. Pharmacother. 2010, 11:115-126.
18. Shinnar S., Pellock J.M., Conry J.A. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy. Eur. J. Paediatr. Neurol. 2009, 13:3-9.
19. Sills G., Brodie M. Pharmacokinetics and drug interactions with zonisamide. Epilepsia 2007, 48:435-441.
20. Simister R.J., Sander J.W., Koepp M.J. Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability. Epilepsy Behav. 2007, 10:336-339.
21. Stephen L.J., Kelly K., Wilson E.A., Parker P., Brodie M.J. A prospective audit of adjunctive zonisamide in an everyday clinical setting. Epilepsy Behav. 2010, 17:455-460.
22. Tan H.J., Martland T.R., Appleton R.E., Kneen R. Effectiveness and tolerability of zonisamide in children with epilepsy: a retrospective review. Seizure 2010, 19:31-35.
23. Tosches W., Tisdell J. Efficacy and safety of long-term zonisamide monotherapy and adjunctive therapy. Epilepsia 2005, 46(Suppl. 6):143. (abstract p. 346).
24. Walker M.C., Sander J.W. Difficulties in extrapolating from clinical trial data to clinical practice: the case of antiepileptic drugs. Neurology 1997, 49:333-337.
25. White J.R., Walczak T.S., Marino S.E., Beniak T.E., Leppik I.E., Birnbaum A.K. Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control study. Neurology 2010, 75:513-518.
26. Wroe S., Brodie M.J. Long-term efficacy and safety with zonisamide: interim analysis of an open-label study. Epilepsia 2005, 46(Suppl 6):118. Abstract.
27. Wroe S.J., Yeates A.B., Marshall A. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy. Acta Neurol. Scand. 2008, 118:87-93.
28. Yuen A.W., Singh R., Bell G.S., Bhattacharjee A., Neligan A., Heaney D.C., Duncan J.S., Sander J.W. The long-term retention of pregabalin in a large cohort of patients with epilepsy at a tertiary referral centre. Epilepsy Res. 2009, 87:120-123.
29. Zaccara G., Specchio L.M. Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature. Neuropsychiatr. Dis. Treat. 2009, 5:249-259.